Who owns ABVC BIOPHARMA INC?
- Ticker: ABVC
- CUSIP Number: 00091f304
Tip: Access positions for across all investors
Analyze quarterly positions in Abvc Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Abvc Biopharma stock
Who bought or sold ABVC BIOPHARMA INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Geode Capital Management | 72k | $49k | 30% | Sep 2024 |
|
Vanguard Group | 47k | $36k | 0% | Jun 2024 |
|
Honkamp Krueger Financial Services | 39k | $30k | 100% | Jun 2024 |
|
Northern Trust | 19k | $13k | 100% | Sep 2024 |
|
State Street Corporation | 13k | $10k | 100% | Jun 2024 |
|
Tower Research Capital | 2.6k | $2.0k | 5% | Jun 2024 |
|
Spotlight Asset Group | 100.00 | $77.000000 | 0% | Jun 2024 |
|
Bank of America Corporation | 78.00 | $53.001000 | -70% | Sep 2024 |
|
Who sold out of Abvc Biopharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Citadel Advisors | Jun 2024 | 25k | $20k |
XTX Topco | Jun 2024 | 19k | $15k |